Key Market Indicators
Latvia's pipeline transport volume dropped 13.7% in 2021 to nearly 445 million tonne-kilometres, down from 516 million the year prior. This marks a 21.6% decrease since 2000. Latvia now ranks 24th, with Bulgaria overtaking them at 445.55 million tonne-kilometres. The United States, China and Kazakhstan took the top three spots in this ranking. Latvia's pipeline length is expected to reach 156.57 kilometres by 2026, down from 284.05 kilometres in 2021, a decrease of 10.2% year-on-year. Since 1995, Latvia's supply has declined by 7.4% annually. The country now ranks 16th, with Denmark overtaking them at 284.05 kilometres. Italy, Romania and Poland took second, third and fourth place in this ranking.
Latvia Pipeline Transportation Market Data and Forecasts
How much will Latvia Pipeline Transportation Market grow?
Improve your Knowledge with the latest Indicators and Trends
The global lubricants market has been exhibiting steady growth, driven by industrialization and mechanization in developing economies. Availability of a plethora of products, each with unique functional characteristics catering to diverse industry demands, contributes to this trend. The demanding industrial environment necessitates the use of high performance lubricants to ensure...Read more
The global market for transport of goods through pipelines is witnessing steady growth, driven by an increased demand for crude oil, natural gas, and refined products. Key industry players are investing in the development and expansion of pipeline infrastructure to meet this escalating demand. In addition, advancements in technology have...Read more
The Ophthalmology pipeline is witnessing a rapid evolution fueled by technological advancements and an improved understanding of ocular diseases. Critical diseases, such as Uveitis and Blepharitis, are gaining attention with numerous prospective therapies under development. Uveitis treatments, marked by anti-inflammatory, immunosuppressive drugs and biologicals, are shifting to a more personalized...Read more
In the highly competitive healthcare sector, cancer treatment continues to be a focal point. Both large pharmaceutical firms and burgeoning biotech companies are vigorously researching and developing innovative therapies to combat various types of cancer. The substantial influx of resources into these projects during the H1 2020 timeframe is noteworthy,...Read more
In the first half of 2020, the therapeutic pipeline in the healthcare industry saw strong activity. A significant number of clinical trial pipeline projects were made across varying stages of development - preclinical, clinical, and registration phases. These trials cover a broad range of therapeutic areas, with biotechnology companies working...Read more